News for hackers. Stuff that matters.
Re:Göttingen researchers identify existing drug with potenti... by 3fe9a03ccd14ca5 on Sunday March 08, 2020 @02:16PM (#22519558)
> Moreover, their study suggests that antibody responses raised against SARS-CoV could at least partially protect against SARS-CoV-2 infection.

Interesting idea. Infect everyone with the “mild” version of SARS to protect against the severe one.

Re:Göttingen researchers identify existing drug with potenti... by mytailorisrich on Sunday March 08, 2020 @02:29PM (#22519633)
SARS (SARS-CoV) is more lethal than Covid-19 (SARS-CoV-2)...

You certainly don't want to infect anyone with SARS!

Re:Göttingen researchers identify existing drug with potenti... by Wistar on Sunday March 08, 2020 @03:34PM (#22520018)
Aren't viral vaccinations typically a "dead" strain of the virus? Although I don't really understand what, exactly, that means.
Re:Göttingen researchers identify existing drug with potenti... by totalZero on Sunday March 08, 2020 @04:30PM (#22520398)
In that type of vaccine, it's exactly as you say. They kill the virus with heat or chemicals, then introduce dead virus into the body. The human body learns the structures on the surface of the virus, recognizes those structures as bad, and releases antibodies if they ever reappear.

It's like someone showing you a dead man and saying "he is survived by an identical twin brother that is wanted for murder."

Re:Göttingen researchers identify existing drug with potenti... by ashildr on Monday March 09, 2020 @12:16PM (#22526580)
This old process takes long and needs a lot of ressources. Culturing a virus is slow.

The new vaccine will likely be a protein that provokes an immune reaction to some essential part of the virus and it will be made by more effective means like genetic modification of eg. a pet microbe or yeast.

No egg as a side dish I guess.

Re:Göttingen researchers identify existing drug with potenti... by TazeTSchnitzel on Sunday March 08, 2020 @06:22PM (#22521030)
That is one kind of vaccination, but it's not the only kind, right?
Re:Göttingen researchers identify existing drug with potenti... by Wistar on Tuesday March 10, 2020 @02:08PM (#22537899)
I dug around and found vaccines.gov which says that there are four vaccine types:

• Live-attenuated vaccines: these use a weakened (or attenuated) form of the germ that causes a disease.

• Inactivated vaccines: these use the killed version of the germ that causes a disease.

• Subunit, recombinant, polysaccharide, and conjugate vaccines: these use specific pieces of the germ — like its protein, sugar, or capsid (a casing around the germ).

• Toxoid vaccines: these use a toxin (harmful product) made by the germ that causes a disease. They create immunity to the parts of the germ that cause a disease instead of the germ itself.

https://www.vaccines.gov/basics/types

Re:Göttingen researchers identify existing drug with potenti... by eganist on Sunday March 08, 2020 @02:26PM (#22519618)
> Interesting idea. Infect everyone with the “mild” version of SARS to protect against the severe one.

Two notes:

1. SARS-CoV is the 2003 strain, which is generally accepted as being the more severe - yet more difficult to transmit - strain of coronavirus. So in this case (unless I'm misunderstanding), people who caught and survived the more severe SARS-CoV in 2003-2004 are less likely to be as affected by the milder SARS-CoV-2 strain. Worth noting that the population of people infected by SARS-CoV is not all that high, so the value isn't so much that there's a population protected from SARS-CoV-2 as it's that there's enough of a similarity between the two strains that we could learn a few useful things about treating the latter.

2. The model you described, using a milder agent to protect against a severe one, is the original concept behind vaccines, done by Dr. Edward Jenner with Cowpox to protect against Smallpox. https://en.wikipedia.org/wiki/Smallpox_vaccine